Validation of the Lewis score for the evaluation of small-bowel Crohn’s disease activity

Background and study aims: The Lewis score was developed to measure mucosal inflammatory activity as detected by small-bowel capsule endoscopy (SBCE). The aim of the current study was to validate the Lewis score by assessing interobserver correlation and level of agreement in a clinical setting.

Patients and methods: This was a retrospective, single-center, double-blind study including patients with isolated small-bowel Crohn’s disease who underwent SBCE. The Lewis score was calculated using a software application, based on the characteristics of villous edema, ulcers, and stenoses. The Lewis score was independently calculated by one of three investigators and by a central reader (gold standard). Interobserver agreement was assessed using intraclass correlation (ICC) coefficient and Bland – Altman plots.

Results: A total of 70 patients were consecutively included (mean age 33.9 ± 11.7 years). The mean Lewis score was 1265 and 1320 for investigators and the central reader, respectively. There was a high correlation, both for scores obtained for each tertile (first tertile r = 0.659 – 0.950, second tertile r = 0.756 – 0.906, third tertile r = 0.750 – 0.939), and for the global score (r = 0.745 – 0.928) (P < 0.0001). Interobserver agreement was almost perfect between the investigators and the central reader (first tertile ICC = 0.788 – 0.971, second tertile ICC = 0.824 – 0.943, third tertile ICC = 0.857 – 0.968, global score ICC = 0.852 – 0.960; P < 0.0001). The inflammatory activity was classified as normal (score < 135) in 2.9 % vs. 2.9 %, mild (score ≥ 135 – < 790) in 51.4 % vs. 55.7 %, and moderate to severe (score ≥ 790) in 45.8 % vs. 41.4 % of patients, respectively (P < 0.001).

Conclusion: A strong interobserver agreement was demonstrated for the determination of the Lewis score in a practical clinical setting, validating this score for the reporting of small-bowel inflammatory activity. The Lewis score might be used for diagnosing, staging, follow-up, and therapeutic assessment of patients with isolated small-bowel Crohn’s disease.

• References

• 1 Annese V, Daperno M, Rutter MD et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 2013; 7: 982-1018
• 2 Dionisio PM, Gurudu SR, Leighton JA et al. Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small-bowel Crohn’s disease: a meta-analysis. Am J Gastroenterol 2010; 105: 1240-1248
• 3 Jensen MD, Nathan T, Rafaelsen SR et al. Diagnostic accuracy of capsule endoscopy for small bowel Crohn’s disease is superior to that of MR enterography or CT enterography. Clin Gastroenterol Hepatol 2011; 9: 124-129
• 4 Solem CA, Loftus Jr EV, Fletcher JG et al. Small-bowel imaging in Crohn’s disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc 2008; 68: 255-266
• 5 Mow WS, Lo SK, Targan SR et al. Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol 2004; 2: 31-40
• 6 Tukey M, Pleskow D, Legnani P et al. The utility of capsule endoscopy in patients with suspected Crohn’s disease. Am J Gastroenterol 2009; 104: 2734-2739
• 7 Gralnek IM, Defranchis R, Seidman E et al. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther 2008; 27: 146-154
• 8 Gal E, Geller A, Fraser G et al. Assessment and validation of the new capsule endoscopy Crohn’s disease activity index (CECDAI). Dig Dis Sci 2008; 53: 1933-1937
• 9 Niv Y, Ilani S, Levi Z et al. Validation of the Capsule Endoscopy Crohn’s Disease Activity Index (CECDAI or Niv score): a multicenter prospective study. Endoscopy 2012; 44: 21-26
• 10 Lewis BS. Expanding role of capsule endoscopy in inflammatory bowel disease. World J Gastroenterol 2008; 14: 4137-4141
• 11 Koulaouzidis A, Douglas S, Plevris JN. Lewis score correlates more closely with fecal calprotectin than Capsule Endoscopy Crohn’s Disease Activity Index. Dig Dis Sci 2012; 57: 987-993
• 12 Figueiredo P, Almeida N, Lopes S et al. Small-bowel capsule endoscopy in patients with suspected Crohn’s disease-diagnostic value and complications. Diagn Ther Endosc 2010; DOI: DOI: 10.1155/2010/101284.
• 13 Van Assche G, Dignass A, Panes J et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. J Crohns Colitis 2010; 4: 7-27
• 14 Rosa B, Moreira MJ, Rebelo A et al. Lewis Score: a useful clinical tool for patients with suspected Crohn’s Disease submitted to capsule endoscopy. J Crohns Colitis 2012; 6: 692-697
• 15 Flamant M, Trang C, Maillard O et al. The prevalence and outcome of jejunal lesions visualized by small bowel capsule endoscopy in Crohn’s disease. Inflamm Bowel Dis 2013; 19: 1390-1396
• 16 Park SK, Yang SK, Park SH et al. Long-term prognosis of the jejunal involvement of Crohns disease. J Clin Gastroenterol 2013; 47: 400-408
• 17 Kalla R, McAlindon ME, Drew K et al. Clinical utility of capsule endoscopy in patients with Crohn’s disease and inflammatory bowel disease unclassified. Eur J Gastroenterol Hepatol 2013; 25: 706-713
• 18 Cotter J, Dias de Castro F, Moreira MJ et al. Tailoring Crohn’s disease treatment: the impact of small bowel capsule endoscopy. J Crohns Colitis In press 2014; DOI: 10.1016/j.crohns.2014.02.018.
• 19 Long MD, Barnes E, Isaacs K et al. Impact of capsule endoscopy on management of inflammatory bowel disease: a single tertiary care center experience. Inflamm Bowel Dis 2011; 17: 1855-1862
• 20 Pons Beltran V, Nos P, Bastida G et al. Evaluation of postsurgical recurrence in Crohn’s disease: a new indication for capsule endoscopy?. Gastrointest Endosc 2007; 66: 533-540
• 21 Bourreille A, Jarry M, D’Halluin PN et al. Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn’s disease: a prospective study. Gut 2006; 55: 978-983
• 22 Efthymiou A, Viazis N, Mantzaris G et al. Does clinical response correlate with mucosal healing in patients with Crohn’s disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy. Inflamm Bowel Dis 2008; 14: 1542-1547
• 23 Swaminath A, Legnani P, Kornbluth A. Video capsule endoscopy in inflammatory bowel disease: past, present, and future redux. Inflamm Bowel Dis 2010; 16: 1254-1262
• 24 Denis MA, Reenaers C, Fontaine F et al. Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn’s disease with normal C-reactive protein serum level. Inflamm Bowel Dis 2007; 13: 1100-1105
• 25 Minderhoud IM, Oldenburg B, Wismeijer JA et al. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 2004; 49: 469-474